BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3152961)

  • 1. Improved survival for childhood acute lymphoblastic leukemia: possible effect of protocol compliance.
    Eden OB; Stiller CA; Gerrard MP
    Pediatr Hematol Oncol; 1988; 5(2):83-91. PubMed ID: 3152961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
    Eden OB; Lilleyman JS; Richards S; Shaw MP; Peto J
    Br J Haematol; 1991 Jun; 78(2):187-96. PubMed ID: 2064956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey C; Richards SM
    Lancet; 1995 Jan; 345(8943):143-8. PubMed ID: 7823668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
    Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
    Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRC UKALL X. The UK protocol for childhood ALL: 1985-1990. The Medical Research Council Working Party on Childhood Leukaemia.
    Chessells JM; Bailey CC; Richards S
    Leukemia; 1992; 6 Suppl 2():157-61. PubMed ID: 1578921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
    Richards S; Burrett J; Hann I; Chessells J; Hill F; Bailey C
    Leukemia; 1998 Jul; 12(7):1031-6. PubMed ID: 9665186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
    Hargrave DR; Hann II; Richards SM; Hill FG; Lilleyman JS; Kinsey S; Bailey CC; Chessells JM; Mitchell C; Eden OB;
    Br J Haematol; 2001 Feb; 112(2):293-9. PubMed ID: 11167821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
    Durrant IJ; Prentice HG; Richards SM
    Br J Haematol; 1997 Oct; 99(1):84-92. PubMed ID: 9359507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
    Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
    Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
    Hann I; Vora A; Richards S; Hill F; Gibson B; Lilleyman J; Kinsey S; Mitchell C; Eden OB
    Leukemia; 2000 Mar; 14(3):356-63. PubMed ID: 10720126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of Treating Childhood Acute Lymphoblastic Leukemia in a Low-middle Income Country: 10 Year Experience in Northeast Mexico.
    Jaime-Pérez JC; López-Razo ON; García-Arellano G; Pinzón-Uresti MA; Jiménez-Castillo RA; González-Llano O; Gómez-Almaguer D
    Arch Med Res; 2016 Nov; 47(8):668-676. PubMed ID: 28476194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols.
    Seksarn P; Wiangnon S; Veerakul G; Chotsampancharoen T; Kanjanapongkul S; Chainansamit SO
    Asian Pac J Cancer Prev; 2015; 16(11):4609-14. PubMed ID: 26107212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving outcome of acute lymphoblastic leukemia with a simplified protocol: report from a tertiary care center in north India.
    Trehan A; Bansal D; Varma N; Vora A
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27762058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and prognosis analysis in 188 children with acute lymphoblastic leukemia of China].
    Yang MH; Jia WG; Cao LZ; He YL; Liao N; Chen GL; Luo JM; Xu WQ; Yang J
    Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):498-501. PubMed ID: 19099804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Failure of treatment and protocol compliance in patients with acute lymphoblastic leukemia].
    Tang JY; Xue HL; Gu LJ; Chen J; Pan C; Chen J; Wang YP; Ye H; Dong L; Zou JY
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):490-3. PubMed ID: 16083545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
    Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
    J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
    Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
    Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.